|
Volumn 103, Issue 14, 2011, Pages 1072-1073
|
Comorbidities in the aging breast cancer population: Are current assessments leading to improved outcomes?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TAMOXIFEN;
AGED;
AGING;
BREAST CANCER;
CANCER MORTALITY;
CANCER PATIENT;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COMORBIDITY;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DRUG WITHDRAWAL;
EDITORIAL;
FEMALE;
GERIATRIC ASSESSMENT;
HEART DISEASE;
HUMAN;
HYPERTENSION;
LOCAL THERAPY;
LUNG DISEASE;
OBESITY;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
STROKE;
SYSTEMIC THERAPY;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
BREAST NEOPLASMS;
COMORBIDITY;
FEMALE;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MORTALITY;
PREDICTIVE VALUE OF TESTS;
RISK FACTORS;
SEER PROGRAM;
UNITED STATES;
|
EID: 79960733764
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djr239 Document Type: Editorial |
Times cited : (11)
|
References (6)
|